Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201703002147145Completed
Randomised trial of rocuronium and cisatracurium in class III obesity, sponsored by Tanta University Hospitals. Primary endpoint: Quality of relaxation of both drugs. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201703002147145.